Please assess the completion status of the following clinical trial:

Trial Title: Postoperative Pain Management in Patients Undergoing Intramedullary Nail Fixation After Tibia and Femoral Fractures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients with tibial and femoral shaft fractures~2. Patients undergoing intramedullary nailing~3. Willing to participate in the protocol~Exclusion Criteria:~1. Chronic pain disorder (daily use of oral opioids)~2. Allergy or hypersensitivity to non steroid anti-inflammatory drug~3. Impaired renal, cardiac, or hepatic function~4. History of gastrointestinal bleeding or substance abuse

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 110 Years
- Healthy Volunteers: t

Study Arms:
- Group 1: Intravenous Ketorolac and oral acetaminophen (Type: EXPERIMENTAL): Group 1 will be composed of patients receiving the following standard pain control protocol: ketorolac 30 mg intravenous (IV) every 6 hours for patients younger than 70 years versus ketorolac 15 mg IV every 6 hours for patients older than 70 years, first dose will be administered 30 minutes preoperatively. An additional 1000mg of oral acetaminophen will be administered every 6 hours simultaneously regardless of the age group. Patients who determine pain to be unbearable and wish to opt out of the non-opioid group will receive may do so.
- Group 2: Intravenous Morphine and oral oxycodone (Type: ACTIVE_COMPARATOR): Group 2 will be composed of patients receiving the following pain control protocol: morphine 0.1 mg per kg intravenous every 6 hours with an additional oral oxycodone combined with acetaminophen 2 tabs every 6 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).